Clinical Trial Update: Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

Phase 4 trial investigating erdosteine for cough in COPD was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Erdosteine (Erdotin) (erdosteine)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: WITHDRAWN